Table 1 Clinical parameters for the samples analyzed on array comparative genomic hybridization (aCGH) and expression microarrays.
Primary gastric tumors | Age/sex | Histology | Location |
|---|---|---|---|
14TA | 58/M | Intestinal | Corpus |
200A | 57/F | Intestinal | Corpus |
222A | 50/M | Intestinal | Corpus |
232A | 83/M | Intestinal | Corpus |
3TC | 57/F | Intestinal | Corpus |
4T/N | 72/M | Intestinal | Corpus |
10TB | 59/M | Intestinal | Antrum |
17TA | 77/M | Intestinal | Antrum |
185B | 78/F | Intestinal | Antrum |
1AT/N | 41/F | Diffuse | Corpus |
6TB | 77/F | Diffuse | Corpus |
9TD | 74/F | Diffuse | Antrum |
13TA | 56/F | Diffuse | Antrum |
Gastric cancer cell lines | Age/sex | Histology | Origin |
AGS | 54/F | Adeno-carcinoma | Primary tumor |
KATOIII | 55/M | Diffuse | Pleural effusion |
MKN-1 | 72/M | Adeno-squamous carcinoma | Lymph node metastasis |
MKN-7 | 39/M | Intestinal | Lymph node metastasis |
MKN-28 | 70/F | Intestinal | Lymph node metastasis |
MKN-45 | 62/F | Diffuse | Liver metastasis |
TMK-1 | 21/M | Diffuse | Lymph node metastasis |